IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression and Is Associated with MAPK Signaling and Macrophage-Related Immune Features. [PDF]
Li J +7 more
europepmc +1 more source
Statement of Retraction: N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1. [PDF]
europepmc +1 more source
IGF2BP2-driven serine metabolism promotes the progression of thyroid carcinoma via m<sup>6</sup>A-PHGDH. [PDF]
Zhang Y, Xiao Z, Dong X, Wang Q.
europepmc +1 more source
METTL16 promotes PD-L1 expression and mediates immunosuppression in B-cell lymphomas via m<sup>6</sup>A methylation. [PDF]
Chen Y +5 more
europepmc +1 more source
Hsa_circ_0000231 activates the MAPK pathway via IGF2BP2-mediated CACNA1H mRNA stabilization to promote cervical cancer progression. [PDF]
Ma S, Lin J, Deng X, Li Z, Chen H.
europepmc +1 more source
Correction: METTL3 facilitates tumor progression via an m<sup>6</sup>A-IGF2BP2-dependent mechanism in colorectal carcinoma. [PDF]
Li T +16 more
europepmc +1 more source
Research Progress of IGF2BP2 in Gynecological Malignancies
openaire +1 more source
Erratum: IGF2BP2-modified UBE2D1 Interacts with Smad2/3 to Promote the Progression of Breast Cancer. [PDF]
Guan XQ +13 more
europepmc +1 more source
Research Article IGF2BP2 gene polymorphism in the pathogenesis of vitiligo
Kursat Kargun +3 more
openaire +1 more source
METTL3-Mediated N6-Methyladenosine Modification Activates the EGR1-ZBP1 Axis to Promote PANoptosis-Like Cardiomyocyte Death in Myocardial Ischemia-Reperfusion Injury. [PDF]
Li L +6 more
europepmc +1 more source

